Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mannitol versus hypertonic sodium for intracranial pressure control during elective craniotomy
IRCT20170805035510N7Phase 4Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2022
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Bronchitol and hypertonic saline in intracranial hypertension (IH) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 12 more. Started Feb 2022; status: completed.
02
Drugs
Bronchitolhypertonic saline
03
Conditions
intracranial hypertension (IH)
Beyond the preview
Go deeper on IRCT20170805035510N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170805035510N7.